1996
DOI: 10.1016/s0002-9378(96)80023-8
|View full text |Cite
|
Sign up to set email alerts
|

Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
59
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 75 publications
(63 citation statements)
references
References 18 publications
4
59
0
Order By: Relevance
“…9,10 We and others have shown a progressive increase in maternal plasma ADM levels throughout pregnancy. [11][12][13][14][15][16] In PE, early reports suggested that maternal ADM levels were decreased, but subsequent larger series found no difference from controls. 14,17,18 However, we believe that this indicates a lack of compensatory increase in response to the hypertensive state.…”
mentioning
confidence: 99%
“…9,10 We and others have shown a progressive increase in maternal plasma ADM levels throughout pregnancy. [11][12][13][14][15][16] In PE, early reports suggested that maternal ADM levels were decreased, but subsequent larger series found no difference from controls. 14,17,18 However, we believe that this indicates a lack of compensatory increase in response to the hypertensive state.…”
mentioning
confidence: 99%
“…Occasionally, immunocytochemical staining for AM has also been reported in cytotrophoblast cells and in the mesenchyma and inflammatory cells within the villi (Kanenishi et al, 2001;Macri et al, 1998). The fetal membranes, and, more specifically, the epithelium of the amniotic membrane, also show high levels of AM and its mRNA (Kanenishi et al, 2000(Kanenishi et al, , 2001Kobayashi et al, 2000;Macri et al, 1996b;Makino et al, 1999c). The pattern and intensity of AM immunoreactivity in the first trimester human placenta and fetal membranes were reported to be similar to that in term pregnancy (Macri et al, 1996a;Kanenishi et al, 2001), suggesting that AM secreted from these sites might play an important role in the maintenance of normal pregnancy throughout gestation.…”
Section: Am In Early Developmental Stages Am In Fetoplacental Tissuesmentioning
confidence: 96%
“…Interestingly, significantly higher AM concentration has been found in amniotic fluid as compared to maternal plasma at any gestational age Kanenishi et al, 2001). The amniotic membrane, placenta, and the embryo proper are candidate sources for these elevated levels in the amniotic fluid Kanenishi et al, 2001;Macri et al, 1996b). Both total AM concentration in amniotic fluid Kanenishi et al, 2001), and the mature/total AM concentration ratio (Kanenishi et al, 2001) were significantly increased in late gestation.…”
Section: Clinical Aspects Related To the Levels Of Am In Normal Pregnmentioning
confidence: 99%
See 1 more Smart Citation
“…17 At the cellular level, many studies have described Adm expression in several tissues derived from both the mother and the fetus: ovary, uterus, placenta and fetal membranes. [18][19][20][21][22][23][24] For example, just prior to implantation in mice, Adm is highly expressed in the trophectoderm cells of the early blastocyst and the luminal epithelial cells of the uterine lining. 20,25,26 Shortly after implantation, and during the rapid expansion of the murine decidua, Adm expression is strongly centered within the primary decidual zone, a 3-5 cell-layer thick region surrounding the recently implanted embryo which serves as a temporary and physical barrier to immunological attack.…”
Section: Am Is a Versatile Peptide Hormone Expressed By Both Maternalmentioning
confidence: 99%